Healthcare
EssilorLuxottica S.A.(ESLOY)
Live Price
Offline$101.92
+2.45% today
1Y Change
-29.33%
Window
Jun 26, 2025 → Jun 23, 2026
- Market Cap
- $82.56B
- Revenue Growth
- +3.2%
- EPS Growth
- -6.7%
- Dividend Yield
- 2.2%
Coverage: 248 bars · Jun 26, 2025 → Jun 23, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
EssilorLuxottica S.A. (ESLOY) is a Healthcare stock with a market cap of $82.56B and listed on OTC. The stock last traded around $101.92 and down 29.3% across the available one-year price window (Jun 26, 2025 → Jun 23, 2026). Baseline metrics include revenue growth of +3.2%, EPS growth of -6.7%, a dividend yield of 2.2%. What stands out right now is revenue +3.2%, EPS -6.7%, free cash flow +7.9% with operating margin 11.8% and ROIC 4.5%. The dividend is present but secondary, with a yield around 2.2%. Valuation already assumes a fairly strong business story at P/E 35.7 and price/sales 2.9. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines ESLOY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+3.2% vs +7.6% peer median
Operating Margin
Below sector median
+11.8% vs +19.4% peer median
P/E
Near sector median
35.7 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report landed above expectations
2026 was reported on Feb 11, 2026 with an EPS surprise of +10.2% and a revenue surprise of +5.4%.
The operating picture looks softer than before
Revenue is at +3.2% and EPS is at -6.7%, with operating margin around 11.8%.
The next real check-in already has a date
The next earnings event is scheduled for Jul 28, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -3.3% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS Δ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Feb 11, 2026 | +10.2% | -7.2% | -18.2% | -27.6% |
2025 Jun 30, 2025 | -22.7% | +1.1% | +6.4% | +10.3% |
2024 Dec 31, 2024 | -22.8% | +1.1% | +1.9% | +8.9% |
Benchmark Edge
ESLOY vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
ESLOY
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
ESLOY Max Drawdown
-48.47%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for ESLOY and SPY.
Company Overview
EssilorLuxottica S.A.
Other OTC
EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in North America, Europe, Latin America, Asia, Oceania, and Africa. It operates in five segments: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. The Wholesale segment engages in the manufacture and wholesale distribution of luxury and sports eyewear. The Retail segment retails luxury and sports eyewear. The Lenses and Optical Instruments segment offers lenses and small equipment, including Varilux progressive lenses; Crizal antireflective, anti-smudge, and antistatic lenses; Transitions photochromic lenses; Eyezen lenses for users of computers, tablets, smartphones, and other connected devices; Xperio polarized sun lenses; and Nikon and Kodak corrective lens brands. It also provides lens edging and mounting instruments for opticians and prescription laboratories; optometry instruments for eye care professionals, schools, occupational medicine centers, military, and other institutions; and Transitions Signature Gen 8 photochromic lens, as well as develops solutions for online sales of optical products. The Equipment segment offers digital surfacing machines and lens coating machines to prescription laboratories, integrated optical chains, and lens manufacturers. The Sunglasses and Readers segment provides non-prescription sunglasses and reading glasses under the Foster Grant, Gargoyles, Magnivision, Corinne McCormack, Monkey Monkey, Ryders Eyewear, and SolarShield brands; Reebok, Steve Madden, Betsey Johnson, Nine West, Dockers, French Connection, Ironman, Rawlings, Bodyglove, Panama Jack, Marvel, and Disney; Bolon, Molsion, Qina, and Prosun brands; and Mujosh and Aojo brands. It has a network of 490 prescription laboratories and edging-mounting facilities. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.
- Leadership
- Francesco Milleri
- IPO Date
- Jan 30, 2008
- Employees
- 153.5k
- Street Address
- 1-5 rue Paul CEzanne
- Mailing
- Paris, 75008
- Region
- Paris, FR
- Reporting Currency
- USD
- Investor Line
- 33 1 49 77 42 16
- Last Updated
- Apr 28, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 35.7
- EV/EBITDA
- 14.7
- Price/Sales
- 2.9
- Price/Book
- 2.1
Growth
- Revenue
- +3.2%
- EPS
- -6.7%
- Free Cash Flow
- +7.9%
Profitability
- Gross Margin
- 60.6%
- Operating Margin
- 11.8%
- Net Margin
- 8.1%
- ROE
- 6.0%
- ROIC
- 4.5%
Balance Sheet
- Debt/Equity
- 0.44
- Current Ratio
- 0.99
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.